Comparing two shoulder surgeries for older patients with osteoarthritis
Official title: Study Evaluating Reverse Versus Anatomic Total Shoulder Arthroplasty in Shoulders With Greater Than 15 Degrees of Retroversion in the Treatment of Osteoarthritis: Protocol
Run by Ottawa Hospital Research Institute · NCT05487274 · Data updated 2026-11-12
This study is testing which shoulder surgery works better for older patients with severe arthritis: a total shoulder replacement or a reverse shoulder replacement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Ottawa Hospital Research Institute Academic / other |
| Locations | 1 site (Ottawa, Ontario) |
| Status | Recruiting |
| Started | August 9, 2022 |
| Main results expected | March 31, 2026 |
| Study ends | December 31, 2029 |
| Registry record updated | April 30, 2024 |
| Trial ID | NCT05487274 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 65 and older with idiopathic shoulder osteoarthritis who have not responded to standard non-surgical treatments and have specific glenoid retroversion.
✕Probably not a fit
Patients with active infections, rotator cuff arthropathy, or significant muscle paralysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares total shoulder arthroplasty (TSA) with an augmented glenoid component to reverse shoulder arthroplasty (RSA) in patients aged 65 and older who have advanced glenohumeral osteoarthritis and greater than 15 degrees of glenoid retroversion. The research aims to determine which surgical approach provides better outcomes for this specific patient population. Participants will be randomly assigned to receive either TSA or RSA, and their clinical and functional outcomes will be assessed over time. The study addresses a gap in existing research regarding optimal surgical interventions for older patients with complex shoulder conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and quality of life for older patients suffering from shoulder osteoarthritis.
How similar studies have gone: While few studies have compared these surgical techniques in older populations, existing literature suggests that RSA may offer significant improvements in certain cases, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of idiopathic shoulder OA. 2. Patients who have failed standard non-surgical management of their shoulder OA who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for at least 6 months. Medical management will be defined as: a) The use of drugs including analgesics and nonsteroidal anti-inflammatory drugs, b) Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.), c) Activity modification 3. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss 4. Patients with a glenoid deficiency and \>15 degrees of glenoid retroversion up to a maximum of 26 degrees of glenoid retroversion (i.e. -15.1, -17, -20…etc.) 5. 65 years of age and older Exclusion Criteria: 1. Active joint or systemic infection 2. Rotator cuff arthropathy 3. Significant muscle paralysis 4. Charcot's arthropathy 5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk) 6. Unable to understand the consent form/process 7. Pregnancy 8. Psychiatric illness that precludes informed consent 9. Unwilling to be followed for the duration of the study 10. Retroversion cannot be surgically corrected to within 10 degrees of neutral 11. History of previous shoulder surgery on affected side 12. Rheumatoid arthritis in the affected shoulder
Where it's running
-
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Peter Lapner, MD FRCSC — The Ottawa Hospital
- Study coordinator: Katie McIlquham
- Email: kmcilquham@ohri.ca
- Phone: 613-737-8899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diaphragm-sparing regional anesthesia for shoulder surgery
This study tests whether a suprascapular and infraclavicular nerve block can provide good shoulder surgery pain relief without causing diaphragm problems, compared with the standard interscalene block, in older adults.
-
Lengthening a tendon to reduce shoulder pain after surgery
This study is testing if lengthening a tendon during shoulder surgery can help reduce pain in patients one year after their operation.
-
National Registry for Artery Embolization to Treat Chronic Pain
This study is testing if a procedure that blocks blood flow to painful areas can help people with chronic pain from osteoarthritis and other conditions feel better.
-
Registry to evaluate outcomes of FX Shoulder replacement devices
This study is setting up a registry to see how well FX Shoulder replacement devices work for patients after their surgeries over the next few years.
-
Evaluating outcomes of FX Shoulder Solutions implants for shoulder conditions
This study is testing how well FX Shoulder Solutions implants work for people who have had shoulder replacement surgeries to see if they help patients recover safely and effectively.
-
Evaluation of the PERFORM™ Humeral System for shoulder conditions
This study is testing how safe and effective the PERFORM™ Humeral System is for people who have had shoulder surgery by tracking their recovery and quality of life over the next ten years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.